AG00I8X0

50-57-7 | Vasopressin, 8-L-lysine-

Chemical structure of Vasopressin, 8-L-lysine-, CAS 50-57-7
AG00I8X0
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 50-57-7
Catalog Number AG00I8X0(AGN-PC-0S8M06)
Chemical Name Vasopressin, 8-L-lysine-
EC Number 200-050-5
IUPAC Name (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
InChI InChI=1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1
InChI Key BJFIDCADFRDPIO-DZCXQCEKSA-N
MDL Number MFCD00076754
Molecular Formula C46H65N13O12S2
Molecular Weight 1056.2182
SMILES C([C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2C=CC(O)=CC=2)C(=O)N[C@@]([H])(CC2C=CC=CC=2)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N1)(N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N)=O
UNII 7CZF3L922Y
Synonyms
8 Lysine Vasopressin, 8-Lysine Vasopressin, Diapid, Lypressin, Lys Vasopressin, Lys-Vasopressin, Lysine Vasopressin, Lysyl Vasopressin, Postacton, Vasopressin, 8-Lysine, Vasopressin, Lysine, Vasopressin, Lysyl, LYPRESSIN, Lysine vasopressin, Syntopressin, Lysine pitressin, Lysipressin, Postacton, 50-57-7, L-Lysine vasopressin, Vasopressin-8-lysine, 8-L-Lysinevasopressin, Vasopressin, 8-L-lysine-, UNII-7CZF3L922Y, Diapid, (8-Lysine)vasopressin, Lysine-vasopressin, Vasopressin (lysine form), 8-L-Lysine vasopressin, 7CZF3L922Y, Lipressina [DCIT], [Lys8]-Vasopressin, [8-Lysine]vasopressin, Lipresina [INN-Spanish], Lypressine [INN-French], Lypressinum [INN-Latin], Lysipressin acetate, DSSTox_CID_28501, DSSTox_RID_82773, DSSTox_GSID_48575, L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)-disulfide, Lipressina, Lypressine, Lypressinum, Lysopressin, Lipresina, Lysylvasopressin, EINECS 200-050-5, (Lys8)-Vasopressin, BRN 4648365, CAS-50-57-7, 3-(Phenylalanine)-8-lysine oxytocin, L-lysinamide,, Lysine-ADH, Lypressin [USAN:USP:INN:BAN], NCGC00181743-01, NCGC00181743-02, C46H65N13O12S2, [Lys8]AVP, AC1LD8IK, SCHEMBL33287, GTPL2172, CHEMBL1200690, DTXSID8048575, CHEBI:94802, BJFIDCADFRDPIO-DZCXQCEKSA-N, HY-P0004, L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)-disulfide, LVP, Tox21_112902, Tox21_113427, CL-017, MFCD00076754, AKOS030529559, CS-5838, FT-0656049, Oxytocin, 3-(L-phenylalanine)-8-L-lysine-, Vasopressin, 8-L-lysine- (7CI,8CI,9CI), l]carbonyl]-L-prolyl-N-(2-amino-2-oxoethyl)-, 076L754, BRD-K93331255-001-01-2, 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide, Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2[Disulfide Bridge: 1-6], (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide, (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide, (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide, 1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y, 1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-p rolyl-L-lysylglycinamide, 19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6CI), Glycinamide, L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-, cyclic (1>6)-disulfide, Pitressin, Vasophysin, Vasopressin, Lypressin Acetate, Schweine-Vasopressin, Lysine-8-vasopressin, D09PZZ, Lypressin [USAN:BAN:INN], Lypressin [USAN:INN:BAN], CID644076, CMC_13286, ACN-049469, C46-H65-N13-O12-S2, 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv., Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfidebridge: Cys1-Cys6), L-8, L 8,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited